Autonomix Medical, Inc. (AMIX)

Autonomix Medical, Inc. is trading at $1.81, down 11.27% on the session. The 50 day average sits at $4.05 and the 200 day at $6.92, which puts the stock in a downtrend. RSI is at 20.4, which reads as oversold, and MACD is bearish crossover. Volume is below average.

The nearest support is around $2.05 with resistance near $4.20, so that band frames the current range. Average daily movement is roughly $0.27, or about 15.2% of the share price, which is what any stop placement has to allow for. The overall health score of 16 out of 100 combines a trend score of 0, momentum of 28 and a risk score of 24.

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.